It is curious. Not sure why.
As another example, Roche's other QX ticker, RHHBF, did better than this one with a 25% gain and over 3.6M in dollar volume today...and is now priced at $374, like any big board stock of it's size in that sector.
There are obviously some clear benefits...that someone smarter than me can hopefully enlighten us about.